Graphite Bio, Inc. - GRPH

SEC Filings Our GRPH Tweets

About Gravity Analytica

Recent News

08.11.2026 - LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
08.04.2026 - LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026
07.06.2026 - LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopia
06.24.2026 - LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
06.07.2026 - LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
05.26.2026 - LENZ Therapeutics to Participate in Upcoming Investor Conferences
05.11.2026 - LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
05.04.2026 - LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference
04.20.2026 - LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom
03.24.2026 - LENZ Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Recent Filings